Clinical Trial SignalFDA safety alert monitoring.
Daily monitoring of FDA MedWatch safety alerts and FDA Drug Safety Communications — every official safety notice published by the FDA, surfaced into a single source-backed feed with per-record evidence.
What FDA MedWatch and DSCs are
FDA MedWatch is the FDA's safety information and adverse-event reporting program. Drug Safety Communications (DSCs) are the agency's most formal public statements about emerging drug safety issues — including new warnings, boxed-warning additions, contraindication updates, and recommendations to prescribers and patients. Both are published through FDA RSS feeds and are public information.
What Clinical Trial Signal monitors
MedWatch alerts
Drug Safety Communications
Label changes
Multi-source convergence
Why it matters
A new boxed warning or formal Drug Safety Communication can reshape prescribing, payer coverage, and competitive positioning within days. Reading FDA safety actions in isolation misses sponsor disclosure and label context; this feed connects them.
Who uses FDA safety alert monitoring
Client briefs on safety actions
Competitor program safety reads
Authoritative source-linked alerts
Disease-area safety surveillance
Source caveats
FDA safety actions reflect the agency's judgment based on the data available at the time, and may be updated as new information becomes available. MedWatch and DSCs are not a complete record of all safety information for a product. Clinical Trial Signal does not provide medical advice; treatment decisions must be made by qualified clinicians using complete labeling.
Start tracking FDA safety actions
Free includes live MedWatch alerts. Pro adds daily safety briefs and PDF / CSV export. Analyst Desk adds wire-feed cross-reference. Research Team adds global pharmacovigilance disclosure feeds.